![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessEfficacy of a computer based discontinuation strategy to reduce PPI prescriptions: a multicenter cluster-randomized controlled trial
Deprescribing of inappropriate long-term proton pump inhibitors (PPI) is challenging and there is a lack of useful methods for general practitioners to tackle this. The objective of this randomized controlled ...
-
Article
Open AccessPatients' perspectives on a patient-oriented electronic decision support tool to reduce overuse of proton pump inhibitors (arriba-PPI): a qualitative study in primary care
To evaluate patients’ perspectives and their experiences with a consultation involving a computer-assisted and patient-centered discontinuation strategy (arriba-PPI tool) as part of a German multicenter study ...
-
Article
Open AccessDiabetes-related research priorities of people with type 1 and type 2 diabetes: a cross-sectional study in Germany
To investigate (i) the importance and priorities of research objectives for people with type 1 (T1DM) and type 2 diabetes (T2DM); (ii) subgroups with specific research priorities; (iii) associated factors (e.g...
-
Article
Open AccessCorrection to: Prevalence and patient‑rated relevance of complexity factors in medication regimens of community dwelling patients with polypharmacy
-
Article
Open AccessPrevalence and patient-rated relevance of complexity factors in medication regimens of community-dwelling patients with polypharmacy
To describe the prevalence of complexity factors in the medication regimens of community-dwelling patients with more than five drugs and to evaluate the relevance of these factors for individual patients.
-
Article
Open AccessHIOPP-6 – a pilot study on the evaluation of an electronic tool to assess and reduce the complexity of drug treatment considering patients’ views
A complex drug treatment might pose a barrier to safe and reliable drug administration for patients. Therefore, a novel tool automatically analyzes structured medication data for factors possibly contributing ...
-
Article
Reduziert arriba-PPI die Überversorgung mit Protonenpumpeninhibitoren? Eine Machbarkeitsstudie
Die Verordnungen von Protonenpumpeninhibitoren (PPI) haben sich in den letzten zehn Jahren mehr als verdreifacht. Mit zunehmender Verordnungsprävalenz mehren sich die Hinweise auf Nebenwirkungen. Viele Patient...
-
Article
Open AccessReduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial
Proton pump inhibitors (PPIs) are increasingly being prescribed, although long-term use is associated with multiple side effects. Therefore, an electronic decision support tool with the aim of reducing the lon...